Therapeutic effects of fractionated radioimmunotherapy (RAIT) with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC) Meeting Abstract

cited authors

  • Ocean, A. J.; Guarino, M. J.; Pennington, K. L.; O'Neil, B. H.; Lima, C. S. Rocha; Bekali-Saab, T. S.; Gulec, S. A.; Gold, D. V.; Wegener, W. A.; Goldenberg, D. M.

fiu authors

publication date

  • 2010

published in

Digital Object Identifier (DOI)


  • 28


  • 15

research area

  • Oncology  Web of Science Research Area